Patents by Inventor Rick Gorczynski

Rick Gorczynski has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of Inhibitors of the Ubiquitin Proteasome Pathway as a Method of Increasing Contractility of the Heart
    Publication number: 20070015777
    Abstract: The present invention describes novel uses for inhibitors of the ubiquitin proteasome degradative pathway. In particular it describes methods for improving cardiac function, increasing alpha myosin levels in the heart, and increasing SERCA levels in the heart. The invention also provides methods for treating cardiac hypertrophy through inhibiton of the ubiquitin proteasome.
    Type: Application
    Filed: July 12, 2006
    Publication date: January 18, 2007
    Inventors: Erik Bush, Rick Gorczynski, Keith Koch, Tim McKinsey
  • Enoximone formulations and their use in the treatment of PDE-III mediated diseases
    Publication number: 20060292213
    Abstract: The present invention provides pharmaceutical formulations of the drug enoximone for use in treatment of disease states in which inhibition of PDE-III may be beneficial.
    Type: Application
    Filed: May 26, 2005
    Publication date: December 28, 2006
    Inventors: Michael Gerber, Rick Gorczynski, Michael Bristow
  • Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases
    Publication number: 20060030611
    Abstract: The present invention provides the (R)-(+) enoximone sulfoxide enantiomer, as well as pharmaceutical formulations of the purified (R)-(+) sulfoxide enantiomer. Also provided are methods of treating diseases in which inhibition of PDE-III may be beneficial.
    Type: Application
    Filed: March 22, 2005
    Publication date: February 9, 2006
    Inventors: Michael Bristow, Michael Gerber, Rick Gorczynski
  • Enoximone sulfoxide enantiomers and their use in the treatment of PDE-III mediated diseases
    Publication number: 20060025463
    Abstract: The present invention provides the (S)-(?) enoximone sulfoxide enantiomer, as well as pharmaceutical formulations of the purified (S)-(?) sulfoxide enantiomer. Also provided are methods of treating diseases in which inhibition of PDE-III may be beneficial.
    Type: Application
    Filed: March 22, 2005
    Publication date: February 2, 2006
    Inventors: Michael Bristow, Michael Gerber, Rick Gorczynski